Loading...
XJPX
4925
Market cap40mUSD
Jul 10, Last price  
1,740.00JPY
1D
-0.17%
1Q
0.99%
Jan 2017
-55.27%
IPO
-56.50%
Name

Haba Laboratories Inc

Chart & Performance

D1W1MN
XJPX:4925 chart
P/E
8.65
P/S
0.54
EPS
201.07
Div Yield, %
2.29%
Shrs. gr., 5y
Rev. gr., 5y
-3.23%
Revenues
12.14b
+0.66%
11,042,840,00011,182,798,00011,318,015,00011,809,979,00013,578,544,00013,233,767,00013,786,971,00013,181,178,00014,811,078,00016,135,567,00017,885,688,00019,253,557,00018,369,640,00014,307,709,00012,908,861,00012,038,052,00012,324,210,00012,061,829,00012,141,299,000
Net income
760m
+31.88%
299,831,000393,361,000266,498,00022,127,000537,865,00010,052,000916,354,00044,834,000982,403,0001,213,611,0001,597,847,0002,088,478,0001,313,475,000216,419,000-269,030,000-707,865,000-2,118,627,000576,566,000760,360,000
CFO
1.24b
-23.68%
272,200,000975,563,000362,591,000411,546,000682,490,0001,521,915,0001,540,149,000-178,754,0001,907,071,0001,495,317,0002,670,956,0001,921,810,000675,509,000534,710,0001,714,447,00055,956,000-587,921,0001,621,011,0001,237,182,000
Dividend
Mar 30, 202640 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Tokyo, Japan, in 1983, HABA Laboratories, Inc. develops and distributes a comprehensive range of skincare, hair, and body care items both domestically and across international markets. Their skincare portfolio encompasses facial cleansers, toners, specialized treatments, and squalane oils, while their hair and body offerings include shampoos, conditioners, soaps, and various hair and hand care solutions. Consumers can acquire these products through multiple avenues, such as mail order, their online platform, various retail outlets including drug and variety stores, and at around 70 dedicated HABA shops located in major department stores and shopping complexes.
IPO date
Jun 11, 2003
Employees
654
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT